product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
TCR gamma/delta Antibody (TCR1) [HRP]
catalog :
NBP1-28275H
quantity :
0.1 ml
price :
329 USD
clonality :
monoclonal
host :
mouse
conjugate :
HRP
clone name :
TCR1
reactivity :
human
application :
flow cytometry
more info or order :
product information
brand :
Novus
master code :
NBP1-28275H
SKU :
NBP1-28275H
product name :
TCR gamma/delta Antibody (TCR1) [HRP]
sizes available :
0.1 ml
description :
The TCR gamma/delta Antibody (TCR1) [HRP] from NBP1-28275H is a 6.3e-05 antibody to . This antibody reacts with chicken.
target :
TCR gamma/delta
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
TCR1
conjugate :
HRP
dilution :
Flow Cytometry
host :
Mouse
immunogen :
Outbred chicken thymocytes and Ig-negative blood lymphocytes
isotype :
IgG1 Kappa
purity :
Protein A or G purified
species :
Chicken
gene symbol :
TRG
applications :
Flow Cytometry
USD :
329 USD
alt names :
T cell receptor gamma locus, T-cell antigen receptor, gamma polypeptide, T-cell rearranging gene, gamma, T-cell receptor, gamma cluster, TCRG, TRG
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- CD19 Antibody (HD37) [Allophycocyanin/Cy7] - Chimeric | NBP2-52662APCCY7
- CD19 Antibody (HD37) [PE/Atto594] - Chimeric | NBP2-52662PEATT594
- TCR gamma/delta Antibody (TCR1) [Alexa Fluor™ Plus 680] | NBP1-28275AFP680
- Fibrin beta-chain Antibody (8E5) [PE] | NBP2-81110PE
- Fibrin beta-chain Antibody (8E5) [PerCP] | NBP2-81110PCP
questions and comments
